HAAS, HEINRICH,哈斯 海因里希,HOERNER, SEBASTIAN,霍纳 赛巴斯汀,霍納 賽巴斯汀,ESPARZA BORQUEZ, ISAAC HERNAN,埃斯帕扎 包昆斯 艾萨克,埃斯帕扎 包昆斯 艾薩克,HILLER, THOMAS MICHAEL,希勒 汤玛斯,希勒 湯瑪斯,BATES, FERDIA,贝兹 费尔迪亚,貝茲 費爾迪亞
申请号:
TW107136678
公开号:
TW201927288A
申请日:
2018.10.18
申请国别(地区):
TW
年份:
2019
代理人:
摘要:
The present disclosure relates to methods for preparing RNA lipoplex particles for delivery of RNA to target tissues after parenteral administration, in particular after intravenous administration, and compositions comprising such RNA lipoplex particles. The present disclosure also relates to methods which allow preparing RNA lipoplex particles in an industrial GMP-compliant manner. Furthermore, the present disclosure relates to methods and compositions for storing RNA lipoplex particles without substantial loss of the product quality and, in particular, without substantial loss of RNA activity.本揭示文係關於製備用於在非經口給藥後,特別是靜脈內給藥後將RNA遞送至目標組織的RNA脂質體複合物(lipoplex)粒子之方法,以及包括此RNA脂質體複合物粒子之組成物。本揭示文亦關於得以用符合工業GMP-規範方式製備RNA脂質體複合物粒子之方法。再者,本揭示文係關於在實質上無損失產品品質,及特別是實質上無損失RNA活性下,用於儲存RNA脂質體複合物之方法和組成物。